Theravance Biopharma, Inc.

Theravance Biopharma Inc. is a biopharmaceutical company engaged in the discovery, development, and commercialization of innovative medicines to address unmet clinical needs. Specializing in respiratory diseases, chronic obstructive pulmonary disease (COPD), and other serious illnesses, the company seeks to improve patient outcomes through advanced therapeutic solutions. Theravance Biopharma’s pipeline includes both inhalation products and small molecule drugs, reflecting its commitment to tackling complex medical challenges. Operating primarily within the healthcare and life sciences sectors, it collaborates with other pharmaceutical firms and research organizations to enhance its research capabilities and market reach. Headquartered in George Town, Cayman Islands, with additional operations in the United States, the company plays a significant role in the development of novel treatments that aim to transform patient care standards globally.